BağcıAAksoyFBaşHA. Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with st-segment elevation myocardial infarction. Angiology2021:33197211030053. DOI: 10.1177/00033197211030053. Epub ahead of print.
2.
TosuARKalyoncuogluMBiterHİ, et al. Prognostic value of systemic immune-inflammation index for major adverse cardiac events and mortality in severe aortic stenosis patients after TAVI. Medicina2021;57:588.
3.
ErdoğanMErdölMAÖztürkSDurmazT. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med2020;14:1553–1561.
4.
GokMKurtulA. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J2021;55:91–96.
5.
NozueTMichishitaIIwakiTMizuguchiIMiuraM. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol2009;54:214–220.
6.
NijssenECNelemansPJRennenbergRJ, et al. Intravenous hydration according to current guidelines in the prevention of contrast induced nephropathy-the AMACING trial. J Thorac Dis2017;9:E656–E657.